RECRUITING

Evaluation of Resection Techniques for Pancreatic Tumors

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint. The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.

Official Title

Evaluation of Resection Techniques for Pancreatic Tumors

Quick Facts

Study Start:2016-04-16
Study Completion:2025-04-26
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05128890

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients that have undergone pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC)
  2. * Patients 18 years old or older
  1. * Patients that have not undergone pancreatic resection surgeries
  2. * Patients under 18 years of age

Contacts and Locations

Study Contact

Colette N Ndjom, MS
CONTACT
214-947-4681
ClinicalResearch@mhd.com
Loretta W Bedell, MPH
CONTACT
214 947 4680
MHSIRB@MHD.COM

Principal Investigator

Alejandro Mejia, M.D.
PRINCIPAL_INVESTIGATOR
The Liver Institute, Methodist Dallas Medical Center

Study Locations (Sites)

Methodist Dallas Medical Center
Dallas, Texas, 75203
United States

Collaborators and Investigators

Sponsor: Methodist Health System

  • Alejandro Mejia, M.D., PRINCIPAL_INVESTIGATOR, The Liver Institute, Methodist Dallas Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2016-04-16
Study Completion Date2025-04-26

Study Record Updates

Study Start Date2016-04-16
Study Completion Date2025-04-26

Terms related to this study

Additional Relevant MeSH Terms

  • Surgery
  • Liver Tumor
  • Pancreas Tumor